{"id":13429,"date":"2005-01-02T12:26:33","date_gmt":"2005-01-02T11:26:33","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=13429"},"modified":"2021-06-22T12:32:56","modified_gmt":"2021-06-22T10:32:56","slug":"buti-m-casado-ma-fosbrook-l-esteban-r","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/buti-m-casado-ma-fosbrook-l-esteban-r\/","title":{"rendered":"Buti M, Casado MA, Fosbrook L, Esteban R"},"content":{"rendered":"<div class=\"miniatura_foto\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-13430 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/06\/pharmacoeconomics.jpg\" alt=\"\" width=\"90\" height=\"120\" \/><\/div>\n<p><strong>Buti M, Casado MA, Fosbrook L, Esteban R<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h6 style=\"text-align: justify;\">Financial impact of two different ways of evaluating early virological response to peginterferon alfa-2b plus ribavirin therapy in genotype 1 na\u00efve patients with chronic hepatitis C<\/h6>\n<h6 style=\"text-align: justify;\"><strong>Pharmacoeconomics. 2005;23:1043-55<\/strong><\/h6>\n<div class=\"col80p\">\n<p style=\"text-align: justify;\"><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed?term=Pharmacoeconomics.%202005%3B23%3A1043-1055.%09\" target=\"_blank\" rel=\"noopener\">M\u00c1S INFORMACI\u00d3N<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Buti M, Casado MA, Fosbrook L, Esteban R &nbsp; &nbsp; &nbsp; Financial impact of two different ways of evaluating early virological response to peginterferon alfa-2b plus ribavirin therapy in genotype 1 na\u00efve patients with chronic hepatitis C Pharmacoeconomics. 2005;23:1043-55 M\u00c1S INFORMACI\u00d3N<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[936,923,306],"tags":[],"class_list":["post-13429","post","type-post","status-publish","format-quote","hentry","category-aip-tipo-de-proyecto","category-hepatologia","category-pharmacoeconomics","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13429"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=13429"}],"version-history":[{"count":2,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13429\/revisions"}],"predecessor-version":[{"id":13432,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13429\/revisions\/13432"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=13429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=13429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=13429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}